MedTrace Logo

NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope

NCT03277872 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-10-04

No results posted yet for this study

Summary

Prospective, randomized and controlled who will be conducted in Maisonneuve-Rosemont hospital and whose objectives are:

* To observe if the alterations of the NoL index and the standard monitoring (Mean Arterial Blood Pressure and Heart Rate) (using the variability of NoL index and standard monitoring, peak NoL index and peak standard monitoring values, and number of time passed over their respective threshold for nociceptive response) are more accentuated after laryngoscopy using the classical MAC blade versus single-use disposable blade of the Glidescope.
* To observe the nociceptive response (using the variability of NoL index and standard monitoring, peak NoL index and peak standard monitoring values, and number of time passed over their respective threshold for nociceptive response) related to the insertion of endotracheal tube between vocal cords during the intubation.

Study plans to enroll 50 adult patients scheduled to undergo either general, gynecological, neurological, orthopedic, plastic or urological surgery under general anesthesia and who necessitate endotracheal intubation.

Conditions

  • Intubation
  • Nociceptive Pain
  • Anesthesia
  • Laryngoscopy

Interventions

DEVICE

Laryngoscopy with GlideScope (GVL) Blade

1. st Laryngoscopy with GVL Blade 2. nd Laryngoscopy with MAC Blade 3. rd Laryngoscopy and ETT insertion with either GVL or MAC Blade according to 2nd randomization

DEVICE

Laryngoscopy with MacIntosh (MAC) Blade

1. st Laryngoscopy with MAC Blade 2. nd Laryngoscopy with GVL Blade 3. rd Laryngoscopy and ETT insertion with either GVL or MAC Blade according to 2nd randomization

Sponsors & Collaborators

  • Verathon

    collaborator INDUSTRY

  • Canadian Hospital Specialties Ltd

    collaborator UNKNOWN

  • Ciusss de L'Est de l'Île de Montréal

    lead OTHER

Principal Investigators

  • Philippe Richebe, MD, PhD · Université de Montréal

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-05
Primary Completion
2017-11-07
Completion
2021-07-02

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03277872 on ClinicalTrials.gov